Janux Therapeutics financial statements

제눅스 테라퓨틱스NASDAQ:JANX · Nasdaq · Healthcare · sector #17
$16.79+1.51%
2026-10-06 close

Janux Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $11M. 2024 operating profit was −$99M.

Reported results

Janux Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy